Have multiple conditions? Click here
You are viewing Clinical Trials In Maryland
Have multiple conditions? Click here

Showing 1-100 of 2736
There are 2736 trials in Maryland
Name City State Zip
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE (C1 Inhibitor [Human]) Wheaton MD 20902
Cinryze for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12 Wheaton MD 20902
Study of Adalimumab in Subjects With Axial Spondyloarthritis Wheaton MD 20902
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis Wheaton MD 20902
Gemzar, Cisp, Sunitinib Urothelial Ca Westminister MD 21157
Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer Westminister MD 21157
Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma Westminister MD 21157
Ixabepilone + Carboplatin Metastatic Breast Cancer Westminister MD 21157
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Towson MD 21204
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Towson MD 21204
Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer Towson MD 21204
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Towson MD 21204
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer Towson MD 21204
Gemcitabine Hydrochloride With or Without GDC-0449 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer Towson MD 21204
Online Survey on Computer Password Usage Towson MD 21252
Longitudinal Surveillance Registry (LSR) of ACUITY Spiral Towson MD 21014
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI Towson MD 21014
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Towson MD 21204
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Towson MD 21204
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Towson MD 21204
Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia Towson MD 21204
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Towson MD 21204
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer Towson MD 21204
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Towson MD 21204
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Towson MD 21204
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Towson MD 21204
Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma Towson MD 21204
VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer Towson MD 21204
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Towson MD 21204
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy Towson MD 21204
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Towson MD 21204
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Towson MD 21204
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer Towson MD 21204
Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Towson MD 21204
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Towson MD 21204
Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery Towson MD 21204
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Towson MD 21204
Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct Towson MD 21204
Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery Towson MD 21204
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Towson MD 21204
Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Towson MD 21204
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer Towson MD 21204
Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia Towson MD 21204
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer Towson MD 21204
Acute Pain Caused by Paclitaxel in Patients With Cancer Towson MD 21204
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer Towson MD 21204
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Towson MD 21204
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Towson MD 21204
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer Towson MD 21204
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Towson MD 21204
Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma Towson MD 21204
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer Towson MD 21204
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Towson MD 21204
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary Towson MD 21204
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Towson MD 21204
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Towson MD 21204
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Towson MD 21204
Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer Towson MD 21204
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer Towson MD 21204
Home-Based Programs for Improving Sleep in Cancer Survivors Towson MD 21204
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers Towson MD 21204
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma Towson MD 21204
Study of Tissue and Blood Samples From Patients With High-Grade Glioma Towson MD 21204
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Towson MD 21204
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Towson MD 21204
Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Towson MD 21204
Efficacy of Multimodal Perioperative Analgesia With Periarticular Drug Injection in Total Knee Arthroplasty(TKA) Towson MD 21204
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma Towson MD 21204
Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery Towson MD 21204
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer Towson MD 21204
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma Towson MD 21204
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer Towson MD 21204
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Towson MD 21204
Crux Biomedical Vena Cava Filter Study - United States Towson MD 21204
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Towson MD 21204
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Towson MD 21204
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Towson MD 21204
Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis Towson MD 21204
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) Towson MD
Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia Towson MD 21204
Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment Towson MD
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Towson MD 21204
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Towson MD
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Towson MD
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) Towson MD 21204
Teen Depression Awareness Project (TDAP) Temple Hills MD 20748
Drug Eluting Stent Registry of Thrombosis Takoma Park MD 20912
An Observational Study of Cholesterol in Coronary Arteries Takoma Park MD 20912
Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease Takoma Park MD 20912
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation Takoma Park MD 20912
The INFUSE - Anterior Myocardial Infarction (AMI) Study Takoma Park MD 20912
The Dual Antiplatelet Therapy Study (DAPT Study) Takoma Park MD 20912
Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients Takoma Park MD 20912
Irrigated Ablation System Evaluation for AF Takoma Park MD 20912
Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V Takoma Park MD 20912
Phase 1/2a Trial of Pf GAP p52-/p36- Sporozoite Malaria Vaccine Silver Springs MD 20910
Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance Silver Springs MD 20910
Pharmacokinetic Study of Anti-HIV Drugs During Pregnancy Silver Spring MD 20910
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Silver Spring MD 20910
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Silver Spring MD 20910
View Clinical Trial Facilities in Maryland

Showing 1-100 of 2736
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register